Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 5.367
Filtrer
1.
Zhonghua Yi Xue Za Zhi ; 104(26): 2409-2416, 2024 Jul 09.
Article de Chinois | MEDLINE | ID: mdl-38978364

RÉSUMÉ

Objective: To compare the efficacy of gasless robotic surgery through transaxillary approach and open surgery for papillary thyroid carcinoma (PTC). Methods: The data of patient undergoing robotic surgery through transaxillary approach and traditional open surgery for PTC at the Sun Yat-sen Memorial Hospital, Sun Yat-sen University, from November 2016 to June 2023 were retrospectively analyzed. A 1∶1 propensity score matching (PSM) was performed to balance age, sex, extent of surgery, tumor size, capsule invasion, and multifocality. Surgical data, postoperative pathological data, complications, postoperative 2-month visual analog scale (VAS) scores for aesthetics, and follow-up data were compared between the two groups. Results: A total of 728 PTC patients were included. There were 339 patients in the robotic group, among which 262 were female (77.3%) and 77 were male (22.7%), with the age of [M (Q1, Q3)] 39 (32, 46) years and a body mass index (BMI) of 22.8 (20.7, 25.0) kg/m². Meanwhile, 389 patients were in the open group, among which 290 were female (74.6%) and 99 were male (25.4%), with the age of 47 (38, 55) years and a BMI of 23.2 (21.3, 25.5) kg/m2. Further analysis after PSM (there were 264 cases in both groups) showed that in the subtotal thyroidectomy and central neck dissection (LT+CCND) subgroup, the robotic group had longer operative time, higher blood loss, and greater drainage volume compared with the open group [100 (80, 130) min vs 60 (50, 80) min; 10 (10, 20) ml vs 10 (10, 20) ml; 103 (69, 145) ml vs 75 (57, 98) ml; all P<0.001], and the central lymph node metastasis rate was higher in the robotic group [45.6% (57/125) vs 31.8% (47/148), P=0.019]. In the total thyroidectomy and central neck dissection (TT+CCND) subgroup, the robotic group also had longer operative time, higher blood loss, and greater drainage volume compared with the open group [150 (110, 180) min vs 85 (75, 100) min; 20 (10, 20) ml vs 10 (10, 20) ml; 155 (107, 206) ml vs 90 (70, 120) ml; all P<0.001]. The incidence of chest skin numbness at 3 months postoperatively was higher in the robotic group compared with the open group (12.9% vs 0, P<0.001), while there were no statistically significant differences in other postoperative complications (all P>0.05). The VAS score at 2 months postoperatively was higher in the robotic group compared with the open group [9 (9, 9) vs 8 (7, 9), P<0.001]. Three cases of contralateral lobe recurrence occurred in the open group, while there were no case of recurrence in the robotic group. The 5-year overall survival rate was 100.0% in both the robotic and open groups, and there was no statistically significant difference in the 5-year disease-free survival rate between the robotic and open groups (100.0% vs 98.6%, P=0.068). Conclusion: Gasless robotic surgery through transaxillary approach for total thyroidectomy or lobectomy in the treatment of PTC is safe, feasible, and effective, with good cosmetic outcomes and comparable efficacy to traditional surgery.


Sujet(s)
Aisselle , Interventions chirurgicales robotisées , Cancer papillaire de la thyroïde , Tumeurs de la thyroïde , Thyroïdectomie , Humains , Interventions chirurgicales robotisées/méthodes , Mâle , Femelle , Cancer papillaire de la thyroïde/chirurgie , Adulte , Études rétrospectives , Tumeurs de la thyroïde/chirurgie , Adulte d'âge moyen , Thyroïdectomie/méthodes , Résultat thérapeutique , Durée opératoire , Score de propension
2.
Med Sci Monit ; 30: e942619, 2024 Jul 08.
Article de Anglais | MEDLINE | ID: mdl-38973140

RÉSUMÉ

BACKGROUND Completion thyroidectomy (CTx) is performed following hemithyroidectomy (HTx) when the risk of malignancy persists or is discovered postoperatively. Different surgical approaches, including CTx after HTx (CTx-HTx), total thyroidectomy (TTx), and revision surgery after TTx (RTx-TTx), offer varying risks and benefits, including pathological outcomes and complication rates. Understanding the predictors and rates of malignancy in these procedures is crucial for optimizing surgical management of thyroid disorders. MATERIAL AND METHODS This retrospective study analyzed data from January 2014 to October 2019, including 60 patients each in the CTx-HTx and TTx groups, and 47 in the RTx-TTx group. The CTx-HTx group was subdivided based on benign or malignant findings in CTx specimens. Clinicodemographic data and pathological features such as tumor type, size, side, capsular and vascular invasion, extrathyroidal spread, multifocality, and lymph node metastasis were reviewed. RESULTS Age and sex distributions were similar across groups. In the CTx-HTx group, 76.7% of specimens were benign and 23.3% malignant. No significant predictors of malignancy were found between the benign and malignant subgroups in univariate and multivariable analyses. In the TTx group, 75.0% of initial lobes and 13.3% of contralateral lobes were malignant. TTx was associated with a significant postoperative decrease in calcium and longer hospital stays. Multivariable analysis identified TTx as an independent risk factor for hypocalcemia. CONCLUSIONS Reducing overtreatment in thyroid cancer may involve limiting CTx after HTx and considering more conservative initial surgeries, particularly when indications for TTx are not definitive.


Sujet(s)
Complications postopératoires , Tumeurs de la thyroïde , Thyroïdectomie , Humains , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/anatomopathologie , Mâle , Femelle , Thyroïdectomie/méthodes , Thyroïdectomie/effets indésirables , Études rétrospectives , Adulte d'âge moyen , Adulte , Complications postopératoires/étiologie , Résultat thérapeutique , Réintervention , Sujet âgé
3.
S D Med ; 77(6): 266-269, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-39013099

RÉSUMÉ

BACKGROUND: Pseudocholinesterase (butyrylcholinesterase) deficiency is an acquired or inherited condition in which decreased plasma levels of the pseudocholinesterase enzyme lead to an inability to metabolize the neuromuscular blocking agents succinylcholine and mivacurium, prolonging their paralytic effects. This often results in delayed extubation and additional intensive care requirements in the postoperative period. CASE DESCRIPTION: We describe a case of suspected pseudocholinesterase deficiency in a previously healthy 59-year-old female who underwent a left thyroid lobectomy and isthmusectomy. The patient received 120 mg of succinylcholine chloride before intubation. The patient did not meet extubation criteria following the completion of the procedure approximately two hours after receiving succinylcholine chloride. The patient was transferred to the ICU for respiratory support and for the medication to clear from the patient's system. The patient regained muscle control approximately four hours after receiving succinylcholine chloride and was extubated without complication. The patient shared post-extubation that she had a blood relative with the diagnosis of pseudocholinesterase deficiency. CONCLUSION: Pseudocholinesterase deficiency is rare but can result in potentially serious complications following the administration of succinylcholine chloride, mivacurium, or ester local anesthetics due to reduced metabolism and subsequently increased pharmacodynamic effects. Given the widespread use of succinylcholine chloride as a neuromuscular blocking agent, such as in this case, providers must be aware of the presentation, pathophysiology, diagnosis, and management. Additionally, this case demonstrates the importance of thoroughly inquiring about any personal or family history of anesthetic complications during a preoperative assessment.


Sujet(s)
Butyrylcholine esterase , Erreurs innées du métabolisme , Suxaméthonium , Thyroïdectomie , Humains , Femelle , Adulte d'âge moyen , Butyrylcholine esterase/déficit , Thyroïdectomie/méthodes , Suxaméthonium/effets indésirables , Suxaméthonium/administration et posologie , Erreurs innées du métabolisme/chirurgie , Erreurs innées du métabolisme/diagnostic , Curarisants dépolarisants/effets indésirables , Apnée
4.
Khirurgiia (Mosk) ; (7): 85-91, 2024.
Article de Russe | MEDLINE | ID: mdl-39008701

RÉSUMÉ

OBJECTIVE: To evaluate the effectiveness of prevention of recurrent laryngeal nerve injury depending on thyroid gland lesion and extent of surgery. MATERIAL AND METHODS: There were 2412 thyroid surgeries between 2000 and 2020. Patients were divided into the main group (1689 patients) and the control group (729 patients). Patients with nodular thyroid gland lesions prevailed in both groups (987 (58.4%) and 415 (56.9%), respectively). All ones underwent atraumatic extrafascial desection and thyroid resection (ultrasonic scalpel). RESULTS. T: He upper laryngeal nerve injury occurred in 35 cases (1.4%). The number of surgeries with thyroid remnant preservation was significantly lower in the main group. The number of procedures with subtotal thyroid resection and thyroidectomy increased by 2.4 times (from 414 to 1010 operations, p<0.05). CONCLUSION: Improvement of surgical treatment of thyroid gland lesions consisting in new operative technique of recurrent laryngeal nerve isolation using ultrasonic scalpel reduces the incidence of recurrent laryngeal nerve injury from 2.3% to 1%. At the same time, the number of extended procedures in the main group significantly exceeded that in the control group (by 2.5 times).


Sujet(s)
Lésions du nerf laryngé récurrent , Glande thyroide , Thyroïdectomie , Humains , Lésions du nerf laryngé récurrent/prévention et contrôle , Lésions du nerf laryngé récurrent/étiologie , Mâle , Thyroïdectomie/méthodes , Thyroïdectomie/effets indésirables , Femelle , Adulte d'âge moyen , Adulte , Glande thyroide/chirurgie , Complications postopératoires/prévention et contrôle , Complications postopératoires/étiologie , Complications postopératoires/épidémiologie , Maladies de la thyroïde/chirurgie , Russie/épidémiologie
5.
Langenbecks Arch Surg ; 409(1): 204, 2024 Jul 04.
Article de Anglais | MEDLINE | ID: mdl-38963576

RÉSUMÉ

PURPOSE: Our study aimed to compare the effectiveness and complications of the transoral endoscopic thyroidectomy submental vestibular approach (TOETSMVA) versus the transoral endoscopic thyroidectomy vestibular approach (TOETVA) or conventional open thyroidectomy (COT) in patients with early-stage papillary thyroid carcinoma (PTC). METHODS: We searched online databases up to January 2024. The outcomes were analyzed using RevMan 5.4 and inverse variance. RESULTS: Seven studies (two RCTs and five retrospective cohort studies) were included. We established higher significance differences for TOETSMVA in comparison with TOETVA in terms of all primary outcomes; operation time, hospital stay, number of resected lymph nodes [MD -21.05, 95% CI= -30.98, -11.12; p < 0.0001], [MD -1.76, 95% CI= -2.21, -1.32, p < 0.00001], [MD -2.99, 95% CI= -19.75, 13.76, p < 0.73], [MD -0.83, 95% CI = -1.19 to -0.47; p < 0.00001], respectively, except the drainage volume, it showed no difference [MD -2.99, 95% CI= -19.75, 13.76, p < 0.73]. In secondary outcomes, it was favored only in mandibular numbness and return to normal diet outcomes. Additionally, TOETSMVA compared with COT showed a significant difference in drainage volume, pain, cosmetic effect, and satisfaction score. CONCLUSIONS: TOETSMVA showed a significant improvement compared to the TOETVA in operation time, hospital stay, number of resected lymph nodes, mandibular numbness, and return to normal diet but did not show a difference in drainage volume. However, TOETSMVA was better in cosmetic effect, drainage volume, satisfaction, and pain scores compared with COT. Further RCTs with larger sample size, multicentral, and longer follow-up are necessary to evaluate the limitations.


Sujet(s)
Chirurgie endoscopique par orifice naturel , Cancer papillaire de la thyroïde , Tumeurs de la thyroïde , Thyroïdectomie , Humains , Thyroïdectomie/méthodes , Cancer papillaire de la thyroïde/chirurgie , Cancer papillaire de la thyroïde/anatomopathologie , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/anatomopathologie , Chirurgie endoscopique par orifice naturel/méthodes , Stadification tumorale , Durée opératoire , Résultat thérapeutique
6.
Rev Assoc Med Bras (1992) ; 70(7): e20240001, 2024.
Article de Anglais | MEDLINE | ID: mdl-39045933

RÉSUMÉ

OBJECTIVE: Thyroidectomy is a relatively uncommon procedure in pediatric patients. We aimed to review our 20-year experience of thyroid surgery. METHODS: A total of 39 patients who underwent thyroid surgery from 2003 to 2023 were retrospectively evaluated. All patients were followed preoperatively and postoperatively by our institutional multidisciplinary board. Patients were divided into two groups based on their pathologies: benign and malignant. RESULTS: In total, 39 patients (27 girls and 12 boys) underwent 47 thyroid surgeries (total thyroidectomy in 19 patients and subtotal thyroidectomy in 20 patients, with 8 of them having completion thyroidectomy). Notably, 20 (51%) patients had benign and 19 (49%) patients had malignant pathologies. Median age at operation was 157 (9-223) months in the benign group and 182 (1-213) months in the malignant group. In the benign group, 12 (60%) patients had colloidal goiter and 8 (40%) patients had other conditions. In the malignant group, 12 (63%) patients had papillary thyroid carcinoma, 3 (16%) patients had follicular thyroid carcinoma, 2 (11%) had medullary thyroid carcinoma, and 2 patients had other thyroid malignancies. Overall permanent complication rate was 2 out of 39 (5%), which was similar for both groups (1 hypocalcemia in each group). The median follow-up was 38 months (1-179 months) with no local recurrence or distant metastasis. CONCLUSION: Pediatric thyroidectomies are performed on a heterogeneous group of pediatric patients due to a diverse group of pathologies. A multidisciplinary approach is required for proper initial management and surgical strategy with decreased complication rate and event-free survival of these patients in experienced tertiary centers.


Sujet(s)
Tumeurs de la thyroïde , Thyroïdectomie , Humains , Femelle , Mâle , Thyroïdectomie/méthodes , Enfant , Études rétrospectives , Enfant d'âge préscolaire , Adolescent , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/anatomopathologie , Résultat thérapeutique , Nourrisson , Carcinome papillaire/chirurgie , Carcinome papillaire/anatomopathologie , Maladies de la thyroïde/chirurgie , Complications postopératoires/épidémiologie , Facteurs temps
7.
Langenbecks Arch Surg ; 409(1): 217, 2024 Jul 17.
Article de Anglais | MEDLINE | ID: mdl-39017727

RÉSUMÉ

BACKGROUND: We conducted a systematic review and meta-analysis to evaluate the role of High Energy Devices (HEDs) versus conventional clamp and tie technique in thyroidectomy. This work is endorsed by the Italian Society of Surgical Endoscopy (Italian Society of Endoscopic Surgery and new technologies-SICE) in the broader project on the evaluation of the role of HEDs in different surgical settings with the full health technology assessment report. MEHODS: Inclusion criteria were adult patients (≥ 18 years old) undergoing Thyroidectomy/Parathyroidectomy conducted with High Energy Devices (as ultrasonic (US), radiofrequency (RF), and hybrid energy (H-US/RF)) in the setting of thyroid surgery (both partial and total) for benign and malign diseases. However, some variability was found in included studies and described in the text. This systematic review and meta-analysis were performed according to the Cochrane handbook for systematic reviews, and the recommendations of the 2020 updated Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) guidelines were pursuit. Selection of abstracts was performed in Ryyan system by 2 independent reviewers, and doubts were solved by another independent reviewer. At the end of literature research, Randomized controlled trials and observational studies were included. Risk of Bias was assessed with ROB2 for RCTs, and New Castle Ottawa Scale for Observational studies. RESULTS: The literature search yielded 47 studies, including 29 RCTs and 18 observational studies. Meta-analysis was performed for 29 randomized clinical trials. Outcomes included in the comparison between High Energy Devise and conventional technique groups were operative time, operative blood loss, overall post-operative drainage volume, length of stay, complications, and costs. HED significantly reduced operative time (28 studies, 3097patients; MD -128.8; 95% CI -34.4 to -23.20; I2 = 96%, p < 0.00001, Random-effect), intra-operative blood loss (13 studies, 642 vs 519 patients; SMD -0.82; 95% CI -1.33 to -0.32; I2 = 93%, p < 0.00001, Random-effect), LOS (22 studies, 2808 vs 2789 patients; MD -0.38, 95% CI -0.59 to -0.17; I2 = 98%, p < 0.00001 Random-effect), and healthcare costs (8 studies, 1138 vs 1129 patients, SMD 1.05; 95% CI -0.06 to 2.16; I2 = 99%, p < 0.00001 Random-effect). The rate of overall intraoperative complications was significantly different between both groups (25 studies, 2804 vs 2775 patients; RR 0.88, 95% CI 0.80 to 0.97; I2 = 38%, p = 0.03 Random-effect), but the sensitivity analysis did not find a statistically significant difference (6 studies, 605 vs 594 patients, RR; 95% CI to; I2 = 0%, p = 0.50, Random-effect). There was no difference in the subgroup analysis for the occurrence of transient and permanent RLN palsy, nor hematoma formation and hypocalcaemia. DISCUSSION: Though findings of our systematic review and metanalysis are limited by heterogeneous data, surgeons, hospital managers, and policymakers should note that the use of High Energy Devices compared to conventional clamp and tie technique have reduced operative times, intra-operative blood loss, length of stay, and hospital costs in patients underwent to tyroid surgery. Future work must explore issues of equity to mitigate barriers to patient access to safe thyroid surgical care and define better this initial results.


Sujet(s)
Thyroïdectomie , Humains , Thyroïdectomie/méthodes , Thyroïdectomie/effets indésirables , Thyroïdectomie/instrumentation , Maladies de la thyroïde/chirurgie , Parathyroïdectomie/méthodes
8.
Front Endocrinol (Lausanne) ; 15: 1402447, 2024.
Article de Anglais | MEDLINE | ID: mdl-39022344

RÉSUMÉ

Background: Hypoparathyroidism is the most common complication for patients who undergo total thyroidectomy (TT) with bilateral central lymph node dissection (BCLND). The objective of this retrospective study was to investigate the relationship between parathyroid autotransplantation (PA) and postoperative hypoparathyroidism. Materials and Methods: Four hundred and sixty-five patients with papillary thyroid carcinoma (PTC) who underwent TT with BCLND (including prophylactic and therapeutic BCLND) by the same surgeon were enrolled in this retrospective study. They were divided into five groups based on the number of PAs. Group 0 was defined as no PA, while Group 1, 2, 3, and 4 were considered as 1, 2, 3, and 4 PAs during TT with BCLND, respectively. Results: Transient and permanent hypoparathyroidism occurred in 83 (17.8%) and 2 (0.4%) patients who underwent TT and BCLND, respectively. The incidence of transient hypoparathyroidism increased gradually with an increase in the number of PAs. Compared with the previous group, Groups 2 and 3 had significantly more cases of transient hypoparathyroidism (p=0.03 and p=0.04, respectively). All cases of permanent hypoparathyroidism occurred in the patients without PA. Compared with Group 0, there were more removed central lymph nodes (RCLNs) in patients with one PA. Furthermore, Group 2 had more metastatic central lymph nodes(MCLNs) and RCLNs than Group 1.The number of PAs was the only identified risk factor for transient hypoparathyroidism after the multivariate logistic regression analysis. The median parathyroid hormone level recovered to the normal range within 1 month after surgery. Conclusion: With an increasing number of PAs, the possibility of transient hypoparathyroidism also increases in patients with PTC who undergo TT and BCLND. Considering the rapid recovery of transient hypoparathyroidism in 1 month, two PAs during TT and BCLND could be a good choice, leading to an increase in the central lymph node yield and no permanent hypoparathyroidism. However, this conclusion should be validated in future multicenter prospective studies.


Sujet(s)
Hypoparathyroïdie , Évidement ganglionnaire cervical , Glandes parathyroïdes , Complications postopératoires , Cancer papillaire de la thyroïde , Tumeurs de la thyroïde , Thyroïdectomie , Transplantation autologue , Humains , Hypoparathyroïdie/étiologie , Hypoparathyroïdie/épidémiologie , Mâle , Femelle , Thyroïdectomie/effets indésirables , Thyroïdectomie/méthodes , Glandes parathyroïdes/transplantation , Glandes parathyroïdes/chirurgie , Transplantation autologue/effets indésirables , Études rétrospectives , Adulte , Adulte d'âge moyen , Complications postopératoires/étiologie , Complications postopératoires/épidémiologie , Tumeurs de la thyroïde/chirurgie , Évidement ganglionnaire cervical/effets indésirables , Cancer papillaire de la thyroïde/chirurgie , Études de suivi , Jeune adulte
9.
Int J Pediatr Otorhinolaryngol ; 182: 112021, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38959761

RÉSUMÉ

INTRODUCTION: Postoperative hypocalcaemia is common after thyroidectomy. This study aimed to evaluate whether a standardised post-thyroidectomy protocol using prophylactic calcium and calcitriol reduces hypocalcaemia incidence after total thyroidectomy in children and adolescents. METHODS: A cohort children and adolescents ≤18 years of age undergoing total thyroidectomy between January 2016 and October 2022 in one institution were retrospectively identified and divided into pre-protocol and post-protocol groups. The primary outcome measure was hypocalcaemia (total serum calcium of <2.0 mmol/L; ionised serum calcium of 0.9 mmol/L). Secondary outcome measures were the occurrence of hypercalcaemia (serum Calcium >2.7 mmol/L; ionised calcium >1.31 mmol/L), length of hospitalisation and number of postoperative blood tests. RESULTS: There were 22 patients in each group (mean age 11.8; SD 4.3 years, female 36 %). The rate of hypocalcaemia was significantly higher in the pre-protocol group than the post-protocol group (54 % vs 13.6 %, p = 0.010). Patients in the pre-protocol group had more inpatient blood tests (mean 5.4; SD 3.2) than the post-protocol group (mean 3.3; SD 1.8, p = 0.011), although the total postoperative blood test count was similar between the groups. Six (13.6 %) patients developed hypercalcaemia. The rate of hypercalcaemia was similar between groups (pre-protocol 2, 9.1 %; post-protocol 4, 18.1 %; p = 0.664). Length of hospitalisation was similar between groups. CONCLUSION: Our standardized protocol decreased hypocalcemia and inpatient blood tests after total thyroidectomy in children. Future research should explore if incorporating preoperative calcium and calcitriol treatment, along with intraoperative PTH levels for risk management, can further reduce hypocalcemia rates in paediatric patients.


Sujet(s)
Calcitriol , Calcium , Protocoles cliniques , Hypocalcémie , Complications postopératoires , Thyroïdectomie , Humains , Hypocalcémie/prévention et contrôle , Hypocalcémie/étiologie , Hypocalcémie/épidémiologie , Hypocalcémie/sang , Thyroïdectomie/effets indésirables , Thyroïdectomie/méthodes , Femelle , Enfant , Mâle , Adolescent , Études rétrospectives , Calcium/sang , Calcitriol/usage thérapeutique , Complications postopératoires/prévention et contrôle , Complications postopératoires/épidémiologie , Complications postopératoires/sang , Complications postopératoires/diagnostic , Hormones et agents régulant le calcium/usage thérapeutique
10.
BMJ Case Rep ; 17(6)2024 Jun 18.
Article de Anglais | MEDLINE | ID: mdl-38890112

RÉSUMÉ

Ectopic goitre, presenting as an isolated thoracic mass without connection to the main thyroid gland enlargement, is a rare occurrence. We describe a case where a patient reported persistent dry cough and back pain for 1 year, along with throat discomfort unresponsive to medication. A 2×1 cm swelling was noted over the right anterior aspect of the neck. Extensive evaluation, including chest X-rays and contrast-enhanced CT of the thorax, revealed a mediastinal mass suggestive of an ectopic thyroid.This case presents a distinctive scenario involving the simultaneous presence of ectopic mediastinal and cervical thyroid lesions. Both were effectively managed using a minimally invasive approach, combining video-assisted thoracic surgery for the excision of the mediastinal mass and a bilateral axillo-breast approach for the cervical lesion in a single procedure. This approach yielded minimal morbidity, aesthetically pleasing outcomes and rapid recovery. Remarkably, such a case has not been previously documented in the available literature.


Sujet(s)
Chirurgie thoracique vidéoassistée , Thyroïdectomie , Humains , Thyroïdectomie/méthodes , Chirurgie thoracique vidéoassistée/méthodes , Femelle , Cou/chirurgie , Cou/imagerie diagnostique , Adulte d'âge moyen , Tomodensitométrie , Choristome/chirurgie , Choristome/imagerie diagnostique , Glande thyroide/chirurgie , Glande thyroide/imagerie diagnostique
11.
Lakartidningen ; 1212024 Jun 17.
Article de Suédois | MEDLINE | ID: mdl-38895760

RÉSUMÉ

This retrospective observational study aimed to identify complications and re-admissions after unilateral exploration of the parathyroid, hemithyroidectomy or resection of the thyroid isthmus in patients that underwent ambulatory surgery at Karolinska University Hospital 2018-2019. The medical records of 280 patients were scrutinized by searching for re-admissions within 10 days or frequent contact with the healthcare provider within 30 days. 256 out of 280 patients underwent ambulatory surgery. 22 patients were converted to inpatient care, one because of postoperative bleeding. Five patients had a complication, one recurrent laryngeal nerve palsy and four postoperative infections. One patient was readmitted within 10 days from surgery, not related to the surgery. Our study supports that with adequate selection of patients and postoperative monitoring, ambulatory endocrine neck surgery can be performed without jeopardizing patient safety.


Sujet(s)
Procédures de chirurgie ambulatoire , Complications postopératoires , Thyroïdectomie , Humains , Procédures de chirurgie ambulatoire/effets indésirables , Thyroïdectomie/effets indésirables , Thyroïdectomie/méthodes , Études rétrospectives , Mâle , Femelle , Adulte d'âge moyen , Complications postopératoires/étiologie , Adulte , Sujet âgé , Parathyroïdectomie/effets indésirables , Réadmission du patient/statistiques et données numériques , Sécurité des patients
12.
Curr Oncol ; 31(6): 3603-3614, 2024 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-38920748

RÉSUMÉ

BACKGROUND: Involvement of the recurrent laryngeal nerve (RLN) in papillary thyroid carcinoma (PTC) is an important prognostic factor and is associated with a higher risk of recurrence. This study aimed to retrospectively analyze the outcomes of patients treated with hemithyroidectomy (HT) in PTC patients with an exclusive RLN invasion who could not tolerate staged surgery, did not wish to undergo another operation, or had other reasons. METHODS: A retrospective review was conducted on 163 patients with PTC and exclusive RLN involvement at our institution between 2013 and 2019. Patients were divided into a total thyroidectomy (TT) group and HT group. The clinicopathologic factors and prognostic outcomes were compared between the two groups. A propensity score-matched analysis was carried out to reduce selection bias, with the following covariates: gender, age, tumor size, multifocality, central lymph node metastasis (CLNM), and RLN resection. The Kaplan-Meier method was used for a comparison of recurrence outcomes. RESULTS: In the baseline data of the 163 PTC patients, tumor size (p < 0.001), multifocality (p = 0.011), CLNM (p < 0.001), and RLN resection (p < 0.008) in the TT and HT groups differed significantly, whereas age and gender did not differ between the two groups. The TT group reported significantly higher temporary and permanent hypoparathyroidism than the HT group (p < 0.001 and p = 0.042, respectively). With 72-month median follow-up, 11 (6.7%) patients developed recurrence. After propensity score matching, 24 patients with HT and 43 patients with TT were included. Recurrence-free survival (RFS) in the matched samples showed no difference between the TT and HT groups (p = 0.092). CONCLUSION: Our results indicate that HT may be a feasible treatment for PTC patients with exclusive RLN involvement in specific circumstances without significantly increasing the risk of recurrence. Performing a thorough preoperative examination is crucial to exclude multifocal tumors and lymph node metastasis before undergoing HT.


Sujet(s)
Score de propension , Nerf laryngé récurrent , Cancer papillaire de la thyroïde , Tumeurs de la thyroïde , Thyroïdectomie , Humains , Mâle , Études rétrospectives , Femelle , Cancer papillaire de la thyroïde/chirurgie , Cancer papillaire de la thyroïde/anatomopathologie , Thyroïdectomie/méthodes , Adulte d'âge moyen , Adulte , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/anatomopathologie , Nerf laryngé récurrent/chirurgie , Récidive tumorale locale/chirurgie , Sujet âgé
13.
Sci Rep ; 14(1): 14747, 2024 06 26.
Article de Anglais | MEDLINE | ID: mdl-38926508

RÉSUMÉ

There are no targeted rehabilitation training modalities and assessment tools for patients after transoral endoscopic thyroidectomy vestibular approach (TOETVA). Herein, we develop a new assessment questionnaire and rehabilitation training modality and evaluate its safety and effectiveness. The THYCA-QoL-TOETVA questionnaire was compiled, and reliability and validity analyses were performed. Patients were divided into the new rehabilitation training group (N) or the conventional rehabilitation training group (C), and 1:1 propensity score matching (PSM) was performed after administering questionnaires to patients in both groups. Cervical range of motion (CROM) data were also measured and collected for statistical analysis. The questionnaire used in this study showed good expert authority, coordination, internal consistency, and questionnaire reliability. A total of 476 patients were included after PSM, and the questionnaire results showed that recovery and quality of life were better in the N group than in the C group (124.55 ± 8.171 vs. 122.94 ± 8.366, p = 0.026). Analysis of cervical spine mobility showed that rehabilitation was better in the N group compared to the C group at postoperative one month (flexion: 1.762°, extension: 4.720°, left lateral bending: 3.912°, right lateral bending: 4.061°, left axial rotation: 5.180°, right axial rotation: 5.199°, p value all of these < 0.001), and at postoperative three months (flexion: 2.866°, extension: 2.904°, left lateral bending: 3.927°, right lateral bending: 3.330°, left axial rotation: 4.395°, right axial rotation: 3.992°, p value all of these < 0.001). The THYCA-QoL-TOETVA provides an appropriate and effective tool for measuring the postoperative quality of life of TOETVA patients. This new rehabilitation training can effectively alleviate the problem of limited neck movement and improve the quality of life of patients after TOETVA surgery.Trial registration: ChiCTR2300069097.


Sujet(s)
Qualité de vie , Thyroïdectomie , Humains , Thyroïdectomie/méthodes , Thyroïdectomie/rééducation et réadaptation , Thyroïdectomie/effets indésirables , Femelle , Mâle , Adulte , Adulte d'âge moyen , Enquêtes et questionnaires , Amplitude articulaire , Période postopératoire , Chirurgie endoscopique par orifice naturel/méthodes
14.
Medicine (Baltimore) ; 103(26): e38540, 2024 Jun 28.
Article de Anglais | MEDLINE | ID: mdl-38941410

RÉSUMÉ

RATIONALE: Thyroglossal duct carcinoma, a rare clinical condition characterized by ectopic thyroid adenocarcinoma within thyroglossal duct cysts (TGDCs), typically confirmed through intraoperative rapid pathology, this condition generally has a favorable prognosis. Nevertheless, comprehensive treatment guidelines across all disease stages are lacking, the purpose of this study is to report 1 case of the disease and propose the treatment plan for each stage of the disease. PATIENT CONCERNS: A patient presented with thyroid swelling, classified as C-TIRADS 4A following a physical examination. Preoperative thyroid puncture identified papillary thyroid carcinoma, and genetic testing revealed a BRAF gene exon 15-point mutation. Ancillary tests showed a slightly decreased thyroid stimulating hormone (TSH) level (0.172) with no other significant abnormalities. DIAGNOSES: Preoperative fine-needle aspiration cytology (FNAC) confirmed right-side thyroid cancer. Intraoperative exploration uncovered a TGDC and intraoperative rapid pathology confirmed thyroglossal duct carcinoma. INTERVENTIONS: A Sistrunk operation and ipsilateral thyroidectomy were performed. OUTCOMES: Postoperative recovery was satisfactory. LESSONS: Thyroglossal duct carcinoma is a rare disease affecting the neck. Due to limited clinical cases and the favorable prognosis associated with this condition, there is currently no established set of diagnostic and treatment guidelines. According to tumor size, lymph node metastasis, thyroid status and other factors, the corresponding treatment methods were established for each stage of thyroglossal duct cancer, which laid the foundation for the subsequent treatment development of this disease.


Sujet(s)
Kyste thyréoglosse , Tumeurs de la thyroïde , Humains , Kyste thyréoglosse/chirurgie , Kyste thyréoglosse/anatomopathologie , Tumeurs de la thyroïde/anatomopathologie , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/diagnostic , Tumeurs de la thyroïde/génétique , Cancer papillaire de la thyroïde/anatomopathologie , Cancer papillaire de la thyroïde/chirurgie , Cancer papillaire de la thyroïde/diagnostic , Cancer papillaire de la thyroïde/génétique , Femelle , Thyroïdectomie/méthodes , Mâle , Protéines proto-oncogènes B-raf/génétique , Adulte , Cytoponction
15.
World J Surg Oncol ; 22(1): 173, 2024 Jun 27.
Article de Anglais | MEDLINE | ID: mdl-38937770

RÉSUMÉ

OBJECTIVE: To evaluate sanitary techniques for radical thyroid cancer surgery via the transaxillary approach without inflation single-port endoscopic surgery (TAWISES) and the conventional open anterior cervical approach (COACAS) in a controlled manner. METHODS: This work was a retrospective analysis of the clinical data of 60 patients admitted to our hospital for unilateral radical thyroid cancer surgery between 01/2021 and 12/2022. The control group underwent COACAS (30 patients), and the experimental group underwent TAWISES (30 patients). The patients' operative time, intraoperative bleeding volume, 24-h postoperative pain index, drainage tube carrying time, hospitalization duration and complication rate were compared and analyzed. The patients were followed up for 3, 6 and 12 months postoperatively and evaluated based on numbness, muscular tightness, pain and other discomfort in the neck, as well as satisfaction with social adaptation and cosmetic incisions. The recurrence status was assessed for 1 year in both groups of patients. A questionnaire survey was conducted to assess patient acceptance of the two surgical approaches. The economic characteristics (cost-effectiveness and cost-utility) of the different approaches in our region were evaluated comprehensively. RESULTS: The length of the incision, drainage tube carrying time and hospitalization duration were greater in the experimental group than in the control group (P < 0.05). The differences in complication rate, intraoperative bleeding volume, 24-h postoperative pain index and recurrence rate were not statistically significant between the two groups (P > 0.05). Neck discomfort was greater in the control group, and the difference was statistically significant at the 3-month postoperative follow-up (P < 0.05). The differences at the 6- and 12-month postoperative follow-ups were not statistically significant (P > 0.05). However, mild discomfort was significantly more common in the experimental group (63.33% > 36.67%, 80% > 53.33%, P < 0.05). The experimental group had better social adaptability, greater total medical costs, and better overall patient medical satisfaction than did the control group (P < 0.05). The acceptance of TAWISL was greater than that of COACAS (P < 0.05). CONCLUSION: Compared with COACLAS, TAWISES is safe and effective and better meets the cosmetic, psychological and social adaptation needs of patients. TAWISES is also more cost effective and can be better utilized for the population in our region, filling the gap in surgical modalities for thyroid cancer in in our region.


Sujet(s)
Tumeurs de la thyroïde , Humains , Femelle , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/anatomopathologie , Mâle , Études rétrospectives , Adulte d'âge moyen , Études de suivi , Adulte , Thyroïdectomie/méthodes , Thyroïdectomie/économie , Mastectomie partielle/méthodes , Complications postopératoires , Pronostic , Aisselle , Études cas-témoins , Durée du séjour/statistiques et données numériques , Durée opératoire , Endoscopie/méthodes , Analyse coût-bénéfice , Douleur postopératoire/étiologie
16.
Surg Clin North Am ; 104(4): 751-765, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38944496

RÉSUMÉ

Thyroid carcinoma of follicular cell origin exists on a histopathologic and clinical spectrum. The authors focus on the category of tumors that fall between the very favorable well-differentiated thyroid carcinomas and the very unfavorable anaplastic thyroid carcinomas. These intermediately aggressive tumors include poorly differentiated thyroid carcinoma and the newly defined differentiated high-grade thyroid carcinoma. Both diagnoses require certain histopathologic requirements be met in order to accurately identify these tumors post-operatively. Management remains primarily surgical though adjunctive treatments such as molecular targeted therapies (eg, tyrosine kinase inhibitors) and differentiation therapy (to restore tumor response to radioactive iodine) are also becoming available.


Sujet(s)
Tumeurs de la thyroïde , Thyroïdectomie , Humains , Tumeurs de la thyroïde/thérapie , Tumeurs de la thyroïde/anatomopathologie , Tumeurs de la thyroïde/diagnostic , Thyroïdectomie/méthodes , Grading des tumeurs , Adénocarcinome folliculaire/thérapie , Adénocarcinome folliculaire/anatomopathologie , Adénocarcinome folliculaire/diagnostic , Carcinome anaplasique de la thyroïde/thérapie , Carcinome anaplasique de la thyroïde/anatomopathologie , Carcinome anaplasique de la thyroïde/diagnostic
17.
Surg Clin North Am ; 104(4): 767-777, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38944497

RÉSUMÉ

Thyroidectomy is relatively safe and often can be done as a minimally invasive procedure. Although they may be associated with a learning curve, thoughtful use of intraoperative adjuncts such as energy devices, recurrent laryngeal nerve monitoring, and parathyroid autofluorescence have the potential to make incremental improvements in the safety and efficiency of thyroid surgery. Perhaps many of these adjuncts may be of greatest benefit when used routinely by less experienced surgeons or selectively in higher-risk operations, although their adoption in practice continues to increase overall.


Sujet(s)
Thyroïdectomie , Humains , Thyroïdectomie/méthodes , Surveillance peropératoire/méthodes , Maladies de la thyroïde/chirurgie , Lésions du nerf laryngé récurrent/prévention et contrôle , Lésions du nerf laryngé récurrent/étiologie , Glande thyroide/chirurgie , Imagerie optique/méthodes
18.
Surg Clin North Am ; 104(4): 725-740, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38944494

RÉSUMÉ

Thyroid cancer is the most common endocrine malignancy. With increasing imaging utilization, there has been an increase in the recognition of small, indolent cancers that would otherwise go undiagnosed. Historically, the surgical recommendation for all patients with thyroid cancer was a total thyroidectomy. However, over the last 20 years, there have been numerous studies evaluating the de-escalation of interventions for low-risk thyroid cancers, transitioning from total thyroidectomy to thyroid lobectomy or active surveillance when indicated. Here, we review the current literature and recommendations with each of these treatment options.


Sujet(s)
Cancer papillaire de la thyroïde , Tumeurs de la thyroïde , Thyroïdectomie , Humains , Thyroïdectomie/méthodes , Tumeurs de la thyroïde/thérapie , Tumeurs de la thyroïde/diagnostic , Tumeurs de la thyroïde/chirurgie , Cancer papillaire de la thyroïde/thérapie , Cancer papillaire de la thyroïde/chirurgie , Cancer papillaire de la thyroïde/diagnostic , Cancer papillaire de la thyroïde/anatomopathologie , Observation (surveillance clinique)
19.
Surg Clin North Am ; 104(4): 711-723, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38944493

RÉSUMÉ

Thyroid nodules are widely prevalent, and often discovered incidentally. Malignancy rates are low for incidental thyroid nodules, and overall outcomes are favorable regardless of diagnosis. Patients with thyroid nodules should be evaluated with TSH levels followed by ultrasound of the thyroid and cervical lymph nodes. It is important to recognize sonographic features suspicious for thyroid malignancy and obtain biopsies when indicated according to major society guidelines. The Bethesda System for Reporting Thyroid Cytopathology along with molecular testing can help guide management decisions regarding thyroid nodules. Surgical resection and other emerging technologies are safe and effective for the treatment of thyroid nodules needing intervention.


Sujet(s)
Résultats fortuits , Nodule thyroïdien , Nodule thyroïdien/diagnostic , Nodule thyroïdien/thérapie , Nodule thyroïdien/anatomopathologie , Humains , Thyroïdectomie/méthodes , Tumeurs de la thyroïde/diagnostic , Tumeurs de la thyroïde/thérapie , Échographie , Cytoponction , Glande thyroide/anatomopathologie , Glande thyroide/imagerie diagnostique
20.
BMC Surg ; 24(1): 188, 2024 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-38877435

RÉSUMÉ

BACKGROUND: Guidelines for thyroid surgery have evolved to reflect advances in medical knowledge and decrease the overdiagnosis of low-risk thyroid cancer. Our goal was to analyze the change made in operative thyroid management and the impact on thyroid cancer diagnosis. BACKGROUND: Guidelines for thyroid surgery have evolved to reflect advances in medical knowledge and decrease overdiagnosis of low risk thyroid cancer. Our goal was to study the evolution, over a long period, of pre- and postoperative management and the influence on histological cancer diagnosis and, more particularly, microcancer. METHODS: In this retrospective cohort study, we included 891 consecutive patients who underwent thyroid surgery between 2007 and 2020. RESULTS: Respectively 305, 290 and 266 patients underwent surgery over the 3 periods of 2007-2010, 2011-2015 and 2016-2020. In all three periods, women represented approximately 70% of the population, and the mean age was 54 years old (range: 67). Most surgeries (90%) involved total thyroidectomies. Over the study period, the proportion of preoperative fine needle aspiration (FNA) increased from 13 to 55%, p < 0,01. Cancer was found in a total of 116 patients: 35 (11%) patients between 2007 and 2010, 50 (17%) between 2011 and 2015 and 32 (12%) between 2016 and 2020 (p = 0.08). For all 3 periods, papillary thyroid cancer (PTC) was the most prevalent, at approximately 80%. The proportion of thyroid cancer > T1a increased significantly from 37% (2011-2015 period) to 81% (2016-2020 period), p = 0.001. Patients treated with radioiodine remained relatively stable (approximately 60%) but were more frequently treated with a low dose of radioiodine (p < 0.01) and recombinant human TSH (p < 0.01). Operative thyroid weight decreased over time in all but the low-risk T1a PTC cases. CONCLUSIONS: Over a period of 15 years and according to the evolution of recommendations, the care of patients who underwent thyroid surgery changed with the increased use of preoperative FNA. This change came with a decrease in low-risk T1a PTC.


Sujet(s)
Tumeurs de la thyroïde , Thyroïdectomie , Humains , Études rétrospectives , Femelle , Adulte d'âge moyen , Mâle , Thyroïdectomie/méthodes , Thyroïdectomie/statistiques et données numériques , Thyroïdectomie/tendances , Sujet âgé , Tumeurs de la thyroïde/chirurgie , Tumeurs de la thyroïde/anatomopathologie , Belgique/épidémiologie , Cytoponction/statistiques et données numériques , Guides de bonnes pratiques cliniques comme sujet , Adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE